Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services, has received a two-day suspension order for a drug license at its store in Jangaon, Telangana. The action, stemming from an order received on April 2, 2026, relates to compliance matters under the Drugs and Cosmetics Act. The company has estimated the potential revenue impact of this temporary suspension to be approximately Rs 0.16 lacs.
Suspension Order Details
MedPlus Health Services has disclosed that its subsidiary, Optival Health Solutions Private Limited, has been issued a suspension notice affecting one of its retail locations. The store, situated at Station Road, Jangaon, Telangana, is required to cease operations for a period of two days following an order received on April 2, 2026. The regulatory action pertains to specific compliance requirements under the Drugs and Cosmetics Act, 1940.
Financial and Operational Impact
The company has evaluated the financial implications of this brief operational halt. The total impact is quantified as a potential revenue loss of Rs 0.16 lacs. Aside from the temporary closure of the Jangaon facility, the company’s broader business activities and financial performance remain unaffected. MedPlus continues to manage its retail network in accordance with statutory requirements across its various operational regions.
Source: BSE
